Ceapro Inc. Reports Fourth Quarter and Full Year 2018 Results and Highlights
– 2018 marked by Company’s catalytic pivot from contract manufacturer to biopharmaceutical company and validation of Ceapro’s dedication to innovation – EDMONTON, Alberta, April 11, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “ …